Wu, L.; Zhong, Y.; Wu, D.; Xu, P.; Ruan, X.; Yan, J.; Liu, J.; Li, X.
Immunomodulatory Factor TIM3 of Cytolytic Active Genes Affected the Survival and Prognosis of Lung Adenocarcinoma Patients by Multi-Omics Analysis. Biomedicines 2022, 10, 2248.
https://doi.org/10.3390/biomedicines10092248
AMA Style
Wu L, Zhong Y, Wu D, Xu P, Ruan X, Yan J, Liu J, Li X.
Immunomodulatory Factor TIM3 of Cytolytic Active Genes Affected the Survival and Prognosis of Lung Adenocarcinoma Patients by Multi-Omics Analysis. Biomedicines. 2022; 10(9):2248.
https://doi.org/10.3390/biomedicines10092248
Chicago/Turabian Style
Wu, Liusheng, Yanfeng Zhong, Dingwang Wu, Pengcheng Xu, Xin Ruan, Jun Yan, Jixian Liu, and Xiaoqiang Li.
2022. "Immunomodulatory Factor TIM3 of Cytolytic Active Genes Affected the Survival and Prognosis of Lung Adenocarcinoma Patients by Multi-Omics Analysis" Biomedicines 10, no. 9: 2248.
https://doi.org/10.3390/biomedicines10092248
APA Style
Wu, L., Zhong, Y., Wu, D., Xu, P., Ruan, X., Yan, J., Liu, J., & Li, X.
(2022). Immunomodulatory Factor TIM3 of Cytolytic Active Genes Affected the Survival and Prognosis of Lung Adenocarcinoma Patients by Multi-Omics Analysis. Biomedicines, 10(9), 2248.
https://doi.org/10.3390/biomedicines10092248